| Literature DB >> 25070534 |
Jing Xia, Changying Zeng, Zheng Chen, Kevin Zhang, Xin Chen, Yufei Zhou, Shun Song, Cheng Lu, Ruiju Yang, Zi Yang, Junfei Zhou, Hai Peng, Wenquan Wang, Ming Peng1, Weixiong Zhang.
Abstract
BACKGROUND: Small noncoding RNA (sncRNA), including microRNAs (miRNAs) and endogenous small-interfering RNAs (endo-siRNAs) are key gene regulators in eukaryotes, playing critical roles in plant development and stress tolerance. Trans-acting siRNAs (ta-siRNAs), which are secondary siRNAs triggered by miRNAs, and siRNAs from natural antisense transcripts (nat-siRNAs) are two well-studied classes of endo-siRNAs.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25070534 PMCID: PMC4124141 DOI: 10.1186/1471-2164-15-634
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Novel miRNAs in Cassava and castor bean identified from small-RNA profiling
| No. | Mature_sequence | #. Reads | WGS_ID | Start | End | Strd. | Genomic region | Validation | Name |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
|
| UGGACGCCAUUUUGACAGAUG | 248 | scaffold00847 | 1153336 | 1153495 | + | Intergenic | N | novel-3 |
|
| CAAAUUAUAAUGGCAUUUUGA | 11 | scaffold02022 | 100612 | 100777 | + | Intergenic | nd | novel-10 |
|
| UGGGUAAGUGGGGAAGAUAAC | 90 | scaffold02264 | 510281 | 510416 | + | Intergenic | N | novel-11 |
|
| AAAUGGGACUCAUCAUAUGGUGGG | 50 | scaffold02658 | 994069 | 994318 | + | intron.2_Cassava | Y | novel-14 |
|
| UGGCCUAGAGUAGUGACCUCC | 346 | scaffold02936 | 84627 | 84693 | - | Intergenic | Y | novel-16 |
|
| AGAUGGGUGGCUCGGGAAGAAG | 21209 | scaffold03604 | 533307 | 533466 | - | Intergenic | Y | novel-20 |
|
| UUAUUUGAUCAAGGGAAAUUC | 154 | scaffold03802 | 905079 | 905143 | + | 3'UTR.1_Cassava | N | novel-21 |
|
| UUUGGGGUAAAUUUGGACCAAA | 46 | scaffold05335 | 14983 | 15180 | - | intron.4_Cassava | N | novel-24 |
|
| UGGCCUUUUGAGUUUGAGAAGACA | 100 | scaffold05694 | 371116 | 371230 | - | intron.6_Cassava | N | novel-27 |
|
| UUGGAAGAGCUUACUUUAAAU | 495 | scaffold05875 | 2354583 | 2354832 | - | Intergenic | N | novel-28 |
|
| UCUGAAUCCCUGACGAAGCCU | 243 | scaffold05884 | 79762 | 79829 | + | Intergenic | Y | novel-29 |
|
| UUUAUAUCAUGCAUAAUUAAG | 82 | scaffold05890 | 126 | 236 | - | Intergenic | N | novel-30 |
|
| UGUCGCUGGAGAAAUGGCACUA | 80 | scaffold07240 | 11314 | 11420 | - | Intergenic | nd | novel-38 |
|
| UUUUAAUGAUAGUAUAGGGGU | 12 | scaffold07290 | 137355 | 137549 | + | Intergenic | nd | novel-39 |
|
| UGGGUGGGUGAGUGGAUAAGA | 172 | scaffold07996 | 160667 | 160818 | - | Intergenic | Y | novel-40 |
|
| UCCAGGCAAGGAAAGCUUUUC | 28 | scaffold08542 | 27109 | 27229 | - | Intergenic | N | novel-44 |
|
| UUGAGGGCUGUUUCCAGAAGC | 207 | scaffold10241 | 178034 | 178193 | + | Intergenic | Y | novel-50 |
|
| UCUAUAUGGUCUGCGGUUACC | 219 | scaffold12301 | 237927 | 238086 | + | Intergenic | Y | novel-51-5p |
|
| UGACCGCAGACCAUAUAGAAC | 446 | scaffold12301 | 237927 | 238086 | + | Intergenic | Y | novel-51 |
|
| GGAAUGGGCGGUUUGGGAAAA | 29917 | scaffold04043 | 391309 | 391458 | - | Intergenic | Y | novel-52 |
|
| UUCCCAAUGUCGCCCAUUCCGA | 890 | scaffold04043 | 391309 | 391458 | - | Intergenic | Y | novel-52-3p |
|
| AAAAGGAAGAUGGAGGGCAUGA | 126 | scaffold03264 | 387326 | 387485 | - | Intergenic | nd | novel-53 |
|
| ACUCUCCCUAAAGGCUUCAAC | 3851 | scaffold03581 | 762705 | 762813 | - | Intergenic | Y | novel-54 |
|
| UAUGGGGGGAUUGGGCAAAAU | 38040 | scaffold03604 | 533082 | 533222 | - | intergenic | Y | novel-55-5p |
|
| UUCCCAAGACCUCCCAUACCAG | 654 | scaffold03604 | 533082 | 533222 | - | intergenic | Y | novel-55-3p |
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
|
| UGGGUGAGUGGAGAAGAUAAC | 14 | 30128 | 2013705 | 2013875 | - | intergenic | novel-40 | |
|
| GGAAUGGGCGGUUUGGGAAAG | 3622 | 29586 | 144967 | 145126 | - | intergenic | novel-52 | |
|
| ACUCUCUCUGAAGGCUUCAAA | 4755 | 29742 | 519324 | 519418 | - | intergenic | novel-54 | |
|
| UAUGGGGGGAUCGGGCAAUAUU | 577 | 29660 | 174480 | 174647 | + | intergenic | novel-55-5p | |
|
| UCUUCCCGAGACCUCCCAUACC | 281 | 29660 | 174480 | 174647 | + | intergenic | novel-55-3p | |
|
| UCUUAUAGCAAUCAGGGGACUUG | 296 | 29877 | 66504 | 66639 | + | intergenic | novel-63 | |
|
| UAGCAAAAGAUAGAACCGGAG | 225 | 29904 | 1112560 | 1112809 | + | intergenic | novel-64 | |
|
| UCUGAUAGCAAAAGAUAGAAC | 528 | 29904 | 1112560 | 1112809 | - | intergenic | novel-64as | |
|
| CGAGUCAUCUGACAGAAGUAG | 5102 | 29912 | 1877312 | 1877561 | + | intergenic | novel-65 | |
|
| UGACGUGGCAUGAACUUCGGCA | 756 | 30074 | 662171 | 662379 | - | intron.6_30074.t000092 | novel-66 | |
|
| UCCUCUGUCACAAAUGGCUUCCAG | 182 | 29912 | 1868939 | 1869188 | + | intergenic | novel-67 | |
Included in (A) and (B) are the number of qualified reads from all small-RNA libraries (#. reads), the genomic scaffold ID (WGS_ID), the start and end positions of the hairpins, strand (strd.) and genomic region where a miRNA resides. Included also in (A) and (B) are mature miRNA sequences, named as miRn-5p and miRn-3p, if both sequences had a substantial number of reads. The “Y” or “N” indicates whether the novel miRNA has been detected or not, respectively, in at least one of four chilling treatment samples, and novel miRNAs not selected for validation are marked with “nd”.
Conservation of Euphorbiaceous miRNA families across 9 plant species – (mes), (rco), (ptc), (mtr), (gma), (ath), (vvi), (osa) and (ppt)
| miR | mes | rco | ptc | mtr | gma | ath | vvi | osa | ppt |
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
| |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
| |||
|
|
|
|
| ||||||
|
|
|
|
|
|
|
| |||
|
|
|
| |||||||
|
|
|
| |||||||
|
|
|
|
|
|
Listed in the tables are the numbers of individual members of miRNA families.
Figure 1Experiment validation of sncRNAs in Cassava cultivar SC124. (A) Expression of miRNAs confirmed by qRT-PCR validation, where “selected” is the percent of miRNAs selected for qRT-PCR assays from all expressed miRNAs based on sequencing data, and “Detected” is the percent of the selected miRNAs that can be detected by qRT-PCR in at least one of the four conditions. (B) Examples of validated known and novel miRNAs expressed in three chilling treatments and the normal condition. (C) Amplification curve, dissolution curve, and endpoint gel image of amplicon products of miRNA novel-55. Solid arrows indicate the target band in gel. (D) The hairpin structure of novel-55 with annotated miRNA-5p highlighted in blue. The number in parenthesis represents the number of reads in the sequencing data.
Distribution of genes that are targeted by miRNAs and subsequently produce candidate secondary siRNAs in (A) Cassava and (B) Castor bean, and their function categories
| #. Genes | Transcripts yielding 21-nt enriched siRNAs |
|---|---|
|
| |
| 2 | ATPase E1-E2 type family protein/haloacid dehalogenase-like hydrolase family protein |
| 2 | auxin response factor 8 |
| 2 | auxin signaling F-box 3 |
| 1 | dicer-like 1 |
| 2 | F-box/RNI-like superfamily protein |
| 1 | GRAS family transcription factor |
| 10 | NB-ARC domain-containing disease resistance protein |
| 1 | phosphate transporter 1;3 |
| 1 | scarecrow-like 3 |
| 4 | TAS3 and unannotated loci |
|
| |
| 3 | auxin response factor |
| 1 | auxin signaling F-box |
| 1 | basic helix-loop-helix (bHLH) DNA-binding superfamily protein |
| 1 | Cupredoxin superfamily protein |
| 1 | disease resistance protein (TIR-NBS-LRR class), putative |
| 1 | Galactose oxidase/kelch repeat superfamily protein |
| 2 | GRAS family transcription factor |
| 1 | Integrase-type DNA-binding superfamily protein |
| 1 | Leucine-rich receptor-like protein kinase family protein |
| 1 | Malectin/receptor-like protein kinase family protein |
| 1 | SET domain protein |
| 3 | squamosa promoter binding protein-like |
| 1 | TCP family transcription factor |
| 3 | TAS3 |
Figure 2miR390-triggered siRNAs from in Cassava. (A) Distribution of small-RNA reads. Plotted are the 5′ ends of the reads at each position along the sense (in blue) and antisense (in red) strands within the TAS3c region. The two arrows marked with miR390 indicate the cleavage sites of miR390 on TAS3c.The distribution of the lengths of these small RNAs is shown in the right-top figure. The radial graph in the right-bottom shows the percent of small RNAs with 5′ ends aligned to one of the 21-phasing registers. The registers to which 5′ and 3′ miR390 cleavage sites are aligned are indicated by miR390 5′ and miR390 3′. (B) The two target sites (top) and base pairing of miR390 (bottom) on TAS3c in Cassava. Sense (in blue) and antisense reads (in red) alignments are plotted near the two target sites. The arrows indicate the putative cleavage sites. Phased siRNA reads duplex with ~2 nt 3′ overhang can be observed on the sense (blue) and antisense (red) strands. The yellow colored are the miR390 targets. (C) Conservation of TAS3c between Cassava and Castor bean. The regions marked blue are conserved with identical bases in the two species.
miRNAs and siRNAs cleavage sites detected by 5′RACE
| Genes | Condition | Basepair | Target ID | Annotation | |
|---|---|---|---|---|---|
| miR390-TAS3c binding site #1 | CA + CCA | 1(1) | scaffold05214 | TAS3c | Non-coding gene, the inter-space between NO.1 and NO.2 basepair match is 168 bp. |
| CS | 11(2), 1(6), 0(1) | ||||
| miR390-TAS3c binding site #2 | CA + CCA | 5(1) | |||
| CS | 5(1) | ||||
| miR167-ARF8 | CA + CCA | 9(1), 7(1) | 001923 m | ARF8 | auxin response factor 8 |
| miR393-ABF3 | NC | 10(1), 17(1) | 004520 m | AFB3 | auxin signaling F-box 3 |
| CA + CCA | 11(8) | ||||
| CS | 11(7) | ||||
| tasiAFR3-ARF3 | CA + CCA | 11(1) | 002399 m | ETT/ARF3 | Transcriptional factor B3 family protein/auxin-responsive factor AUX/IAA-related |
| CS | 11(6) | ||||
| tasiARF1-ARF3 | CS | 11(1) | 002399 m | ETT/ARF3 | |
| tasiARF1-ARF4 | CA + CCA | 10(1) | 001979 m | ARF4 | auxin response factor 4 |
| CS | 10(1) | ||||
| tasiARF2-NAC2 | CS | 11(2) | 027253 m | NAC2 | NAC domain containing protein 2 |
| siReport31-CUL4 | CA + CCA | 18(1) | 001768 m | CUL4 | cullin4 |
Each target site was detected by ten clones. “Basepair” column lists the specific cleavage site from the 5′ end of a miRNA or siRNA and the number of clones (in parenthesis) that were detected to have cleavage products.
Figure 3Cleavage sites of ta-siRNAs detected by 5′-RACE in chilling-treated Cassava plants. Shown here are the cleavage sites of (A) tasiARF3 on ARF3 (002399 m), (B) tasiARF1 on ARF3 (002399 m), (C) tasiARF2 on NAC2 (027253 m), and (D) tasiARF1 on ARF4 (001979 m). In each panel, the name of a target, its annotation and the ta-siRNA-binding region are shown on the top and the reversed ta-siRNA sequence on the bottom with conditions shown to the left (CA, CCA and/or CS). An arrow indicates a cleavage on the target gene. The first number atop of an arrow refers to the cleavage site within the ta-siRNA-binding region from the 5′ end of the small RNA, and the following number is the number of clones (out of 10) detected by cloning of amplified the specific PCR product. A number with prefix “+” or “-” refers to, respectively, the cleavage site located upstream or downstream of the base-pairing region on the target gene. The number on a solid line indicates the distance between the cleavage site and the boundary of ta-siRNA-binding region.
cis-NAT pairs that generate siRNAs in Cassava and castor bean
| + Strand | - Strand | |||||||
|---|---|---|---|---|---|---|---|---|
| ID | Scaffold | Type | Start | End | # Reads in OL a | 21 nt% b | # Reads in OL a | 21 nt% b |
|
| ||||||||
| cis-NAT-1 | scaffold07238 | 3′-3′ | 376957 | 377910 | 40 | 85.0% | 175 | 66.3% |
| cis-NAT-2 | scaffold11378 | 3′-3′ | 285315 | 286689 | 53 | 57.2% | 10 | 60.0% |
| cis-NAT-3 | scaffold08316 | 3′-3′ | 598264 | 598958 | 33 | 60.6% | 7 | 100.0% |
| cis-NAT-4 | scaffold12317 | 3′-3′ | 65657 | 66262 | 26 | 65.4% | 6 | 83.3% |
| cis-NAT-5 | scaffold03802 | 3′-3′ | 435292 | 436201 | 4 | 100.0% | 24 | 54.2% |
| cis-NAT-6 | scaffold11581 | 3′-3′ | 786965 | 787920 | 7 | 85.7% | 15 | 53.3% |
| cis-NAT-7 | scaffold06688 | 3′-3′ | 321683 | 322092 | 8 | 87.5% | 7 | 85.7% |
|
| ||||||||
| cis-NAT-8 | 29701 | 5′-5′ | 185445 | 186292 | 112 | 94.6% | 152 | 94.7% |
aOL stands for overlapping regions.
bAbundance of 21-nt reads expressed as the percentage of the total reads.
Figure 4A cis-NAT candidate locus yields 21-nt enriched siRNAs. (A) cis-NAT pair of no apical meristem gene (NAM, 013132 m) and unannotated gene (020539 m) in Cassava. The EST track displays the EST sequences from the Phytozome database [36]. (B) Small RNAs from the positive and negative strands are displayed above and below the NAT pairs, respectively. The red and blue regions on the gene model represent exons and introns, respectively.
Figure 5Experimental validation of differential expression of (A) known miRNAs, (B) novel miRNAs and (C) ta-siRNAs in three chilling stress treatments, CA, CCA and CS, with respect to the normal condition in Cassava SC124 cultivar.